Status:
COMPLETED
Ultrafast Ultrasound Imaging Assesment of Carotid Plaque Neovascularization
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Carotid Stenosis
Carotid Artery Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke is the second leading cause of death in the Western world and the leading cause of major lifelong disability. About 15% of strokes are secondary to thrombosis or embolization of an unstable ath...
Detailed Description
see above
Eligibility Criteria
Inclusion
- The patient is over 18
- The patient is scheduled for carotid endarterectomy within 30 days at most
- The patient has a social security system
Exclusion
- Non-atheromatous carotid stenosis (radiation)
- Contraindication of the use of SonoVue ultrasound contrast media. Hypersensitivity to the active ingredient or any of the following excipients: Macrogol 4000; Distearoylphosphatidylcholine; Dipalmitoylphosphatidylglycerol sodium; Palmitic acid.
- The patient has any of the following conditions: right-left shunt, severe pulmonary hypertension (pulmonary blood pressure \> 90 mm Hg), uncontrolled systemic hypertension and respiratory distress syndrome.
- Lack of social security coverage, patient under justice
- Allergy to ultrasound gel
- Pregnancy. (As a precautionary measure, it is best to avoid using SonoVue during pregnancy according to SPC)
- Patient under guardianship or curatorship or under the protection of justice.
- Patient unable or unwilling to give written consent
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04470687
Start Date
March 17 2021
End Date
September 15 2022
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital europeen Georges-Pompidou
Paris, France, 75015